S. Shukla Sanjay's Insider Trades & SAST Disclosures
S. Shukla Sanjay's most recent trade in Atyr Pharma Inc was a trade of 10,375 Restricted Stock Unit done . Disclosure was reported to the exchange on Feb. 3, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern S. Shukla Sanjay.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Atyr Pharma Inc | Sanjay S. Shukla | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2025 | 10,375 | 10,375 | - | - | Restricted Stock Unit | |
| Atyr Pharma Inc | Sanjay S. Shukla | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2025 | 10,375 | 146,923 (1%) | 0% | - | Common Stock | |
| Atyr Pharma Inc | Sanjay S. Shukla | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.81 per share. | 31 May 2024 | 20,000 | 136,548 (1%) | 0% | 1.8 | 36,140 | Common Stock |
| Atyr Pharma Inc | Shukla Sanjay S. | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Feb 2024 | 10,375 | 116,548 (1%) | 0% | - | Common stock | |
| Atyr Pharma Inc | Shukla S. Sanjay | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Feb 2024 | 10,375 | 20,750 | - | - | Restricted Stock Unit | |
| Atyr Pharma Inc | Sanjay Shukla S. | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 600,000 | 600,000 | - | - | Employee Stock Option (right to buy) | |
| Atyr Pharma Inc | Sanjay Shukla S. | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.18 per share. | 11 Dec 2023 | 12,000 | 106,173 (1%) | 0% | 1.2 | 14,136 | Common Stock |
| Atyr Pharma Inc | Sanjay Shukla S. | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.17 per share. | 11 Dec 2023 | 3,000 | 94,173 (1%) | 0% | 1.2 | 3,510 | Common Stock |
| Atyr Pharma Inc | S. Shukla Sanjay | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.11 per share. | 10 Nov 2023 | 13,578 | 91,173 (1%) | 0% | 1.1 | 15,085 | Common Stock |
| Atyr Pharma Inc | Sanjay Shukla S. | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.14 per share. | 10 Nov 2023 | 1,422 | 77,595 (0%) | 0% | 1.1 | 1,618 | Common Stock |
| Atyr Pharma Inc | Sanjay S. Shukla | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 2.01 per share. | 28 Jul 2023 | 15,000 | 76,173 (0%) | 0% | 2.0 | 30,224 | Common Stock |
| Atyr Pharma Inc | Sanjay S. Shukla | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 336,096 | 336,096 | - | - | Employee Stock Option (right to buy) | |
| Atyr Pharma Inc | Sanjay S. Shukla | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2023 | 10,375 | 61,173 (0%) | 0% | - | Common stock | |
| Atyr Pharma Inc | Sanjay S. Shukla | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2023 | 10,375 | 31,125 | - | - | Restricted Stock Unit | |
| Atyr Pharma Inc | Sanjay S. Shukla | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 2.14 per share. | 21 Nov 2022 | 10,000 | 50,798 (0%) | 0% | 2.1 | 21,405 | Common Stock |
| Atyr Pharma Inc | Sanjay S. Shukla | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 2.88 per share. | 01 Jul 2022 | 15,000 | 40,798 (0%) | 0% | 2.9 | 43,164 | Common Stock |
| Atyr Pharma Inc | Sanjay S. Shukla | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2022 | 516,280 | 516,280 | - | - | Employee Stock Option (right to buy) | |
| Atyr Pharma Inc | Sanjay S. Shukla | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2022 | 83,000 | 83,000 | - | - | Employee Stock Option (right to buy) | |
| Atyr Pharma Inc | Sanjay S. Shukla | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2022 | 41,500 | 41,500 | - | - | Restricted Stock Units | |
| Atyr Pharma Inc | Sanjay S. Shukla | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 6.76 per share. | 07 Jan 2022 | 5,000 | 25,798 (0%) | 0% | 6.8 | 33,807 | Common Stock |
| Atyr Pharma Inc | Sanjay S. Shukla | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 8.58 per share. | 15 Nov 2021 | 2,500 | 20,798 (0%) | 0% | 8.6 | 21,438 | Common Stock |
| Atyr Pharma Inc | Sanjay S. Shukla | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2021 | 207,000 | 207,000 | - | - | Employee Stock Option (Right to buy) | |
| Atyr Pharma Inc | Sanjay S. Shukla | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 4.01 per share. | 18 May 2021 | 10,000 | 18,298 (0%) | 0% | 4.0 | 40,100 | Common Stock |
| Atyr Pharma Inc | Sanjay S. Shukla | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2021 | 1,785 | 0 | - | - | Restricted Stock Unit | |
| Atyr Pharma Inc | Sanjay S. Shukla | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2021 | 1,785 | 9,076 (0%) | 0% | - | Common stock | |
| Atyr Pharma Inc | Sanjay S. Shukla | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 7.66 per share. | 06 Feb 2021 | 778 | 8,298 (0%) | 0% | 7.7 | 5,959 | Common stock |
| Atyr Pharma Inc | Sanjay S. Shukla | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2021 | 112,469 | 112,469 | - | - | Employee Stock Option (right to buy) | |
| Atyr Pharma Inc | Sanjay S. Shukla | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 4.27 per share. | 19 Jun 2020 | 6,000 | 7,291 (0%) | 0% | 4.3 | 25,620 | Common Stock |
| Atyr Pharma Inc | Sanjay S. Shukla | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2020 | 80,000 | 0 | - | - | Employee Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges